Results

Total Results: 330 records

Showing results for "sedation".

1. Appendix-F2-Surveillance-Report-1 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-f2-surveillance-report-1.xlsx
   November 22, 2021 - Cognitive Effects Cognitive Effects Cognitive Effects Cognitive Effects Dry Mouth Dry Mouth Dry Mouth Sedation … Sedation Sedation Sedation Dizziness Dizziness Dizziness Weight Gain Weight Gain Weight Gain Author … Cognitive Effects Dizziness Dizziness Dizziness Peripheral Edema Peripheral Edema Peripheral Edema Sedation … Sedation Sedation Sedation Weight Gain Weight Gain Weight Gain Author, Year Quality Pain Population

2. Crosscutting-Horizon-Scan-High-Impact-1412 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
   December 01, 2014 - using Sedasys to benzodiazepine/opiate-mediated sedation. … Endoscopist/nurse teams administered both sedation methods. … of propofol for sedation during endoscopies, experts also commented. … compared with benzodiazepine/opioid sedation. … An assessment of computer-assisted personalized sedation: a sedation delivery system to administer

3. Crosscutting-Horizon-Scan-High-Impact-1406 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
   June 01, 2014 - delivered using Sedasys to benzodiazepine/opiate-mediated sedation. … sedation during routine endoscopy procedures. … Endoscopist/nurse teams administered both sedation methods. … compared with benzodiazepine/opioid sedation. … An assessment of computer-assisted personalized sedation: a sedation delivery system to administer

4. App-F2-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
   September 20, 2022 - Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Nausea: n Nausea: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Dry Mouth: n Dry Mouth: N N Randomized Dizziness: … : Specific AE Sedation: n Sedation: N N Randomized Dizziness: n Dizziness: N N Randomized Weight Gain … Randomized Dizziness: n Dizziness: N N Randomized Peripheral Edema: n Peripheral Edema: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Weight Gain: n Weight Gain: N N Randomized Khasbage

5. App-F2-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
   September 20, 2022 - Specific AE Cognitive Effects: n Cognitive Effects: N N Randomized Dry Mouth: n Dry Mouth: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Dizziness: n Dizziness: N N Randomized Weight Gain … Randomized Dizziness: n Dizziness: N N Randomized Peripheral Edema: n Peripheral Edema: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Weight Gain: n Weight Gain: N N Randomized Lee, 2020

6. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
   September 20, 2022 - Specific AE Cognitive Effects: n Cognitive Effects: N N Randomized Dry Mouth: n Dry Mouth: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Dizziness: n Dizziness: N N Randomized Weight Gain … Randomized Dizziness: n Dizziness: N N Randomized Peripheral Edema: n Peripheral Edema: N N Randomized Sedation … : Specific AE Sedation: n Sedation: N N Randomized Weight Gain: n Weight Gain: N N Randomized Khasbage

7. Acute Migraine Treatment in Emergency Settings | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/migraine-emergency/research
   November 27, 2012 - The risk of sedation following administration of metoclopramide or neuroleptic agents was 17 percent. … The most common short-term side effects for triptans were skin reactions, local reactions, and sedation … For patients receiving DHE, the most common side effects were skin and local reactions, sedation, digestive

8. Antipsychotics for the Prevention and Treatment of Delirium: Evidence Summary (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/delirium-summary.pdf
   September 01, 2019 - the effect of antipsychotics on cognitive function, delirium severity, or caregiver burden, or for sedation … 12 The trials for prevention of delirium evaluated delirium incidence, length of hospital stay, sedation … The treatment trials primarily evaluated hospital length of stay and sedation effects, with most of … stay in the hospital, inappropriate continuation of antipsychotic medication once initiated, and sedation … insufficient evidence to determine the effect of haloperidol versus placebo on delirium severity, sedation

9. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-250-cannabis-other-plant-based-treatments-evidence-summary.pdf
   October 01, 2021 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … associated with moderate improvement in pain severity, no effect on overall function and increased risk of sedation … [SOE]a Dizziness Effect Size (N Studies) [SOE]a Nausea Effect Size (N Studies) [SOE]a Sedation … the results with recent systematic reviews that used the same methodology, suggests that the risk of sedation … were found with comparable THC to CBD ratio oral sprays, with large increased risk of dizziness and sedation

10. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
    October 01, 2021 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … associated with moderate improvement in pain severity, no effect on overall function and increased risk of sedation … [SOE]a Dizziness Effect Size (N Studies) [SOE]a Nausea Effect Size (N Studies) [SOE]a Sedation … the results with recent systematic reviews that used the same methodology, suggests that the risk of sedation … were found with comparable THC to CBD ratio oral sprays, with large increased risk of dizziness and sedation

11. Plant-Based-Chronic-Pain-Appendix-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-appendix-f5.xlsx
    January 12, 2021 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … NR (assumed 0) Dizziness: 13.5% (29/215) vs. 9.7% (21/216) Nausea: 16.7% (36/215) vs. 9.7% (21/216) Sedation

12. Living Systematic Review on Cannabis for Chronic Pain – Quarterly Progress Report 2 Tables (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-q2-tables-f5.xlsx
    March 15, 2021 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … NR (assumed 0) Dizziness: 13.5% (29/215) vs. 9.7% (21/216) Nausea: 16.7% (36/215) vs. 9.7% (21/216) Sedation

13. Draft-Appendix-Pbt-Cohort-Studies (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/draft-appendix-pbt-cohort-studies.xlsx
    May 11, 2021 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

14. Cer-243-Prehospital-Airway-Management-Appendix-F-1 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
    January 01, 2016 - (etomidate-only) 24 Harms Aspiration ITT Technique/Device ETI: RSI vs. sedation-facilitated No cases … No medication Sedation-facilitated vs. … No medication Sedation-facilitated vs. … Sedation-facilitated RSI vs. … Sedation-facilitated RSI vs.

15. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
    January 01, 2018 - SAE SAE Cognitive Effects Cognitive Effects Cognitive Effects Cognitive Effects Nausea Nausea Nausea Sedation … Sedation Sedation Sedation Serotonin Syndrome Serotonin Syndrome Serotonin Syndrome Serotonin Syndrome … , 2009 Fair LBP SNRI Duloxetine 120 mg/d 13 Short 27 112 3 112 Confusional state 0 112 NR 14 112 NR Sedation … Sedation Sedation Sedation Weight Gain Weight Gain Weight Gain Author, Year Quality Pain Population … Sedation Sedation Sedation Author, Year Quality Pain Population Drug Class Drug Assessment Time (wk

16. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research-protocol
    July 01, 2010 - Inhibitor: None Yes Levetiracetam Synaptic vesicle release modulation Partial Neurological: sedation … Yes Phenobarbital Potentiate GABA receptor function Partial Tonic-Clonic Neurological: sedation … No Tiagabine Increase GABA availability Partial Tonic-Clonic Neurological: confusion, sedation … channel inhibition Partial Tonic-Clonic Lennox-Gastaut Neurological: psychomotor slowing, sedation … None Enzyme Inhibitor: None No Zonisamide Na+ channel inhibition Partial Neurological: sedation

17. Draft Report: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/draft-report-plant-based-treatment.pdf
    March 01, 2021 - There was a large increased risk of dizziness and sedation and a moderate increased risk of nausea ( … dizziness: 6 RCTs, N=866, 30% vs. 8%, relative risk [RR] 3.57, 95% CI 2.42 to 5.60, I2=0%; sedation: … There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … The risk of sedation and dizziness appears similar with cannabis-related products, opioids, and the … Important harms include typical adverse effects such as dizziness, sedation and nausea, but may also

18. PICO #1 Population(s): Children with infantile hemangiomas (IHs) Intervention(s): Early referral Comparator(s): Delayed referral Outcomes(s): Minimization of functional impairment and/or cosmetic deformity PICO #2 Population(s): Children… | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/pico-1-populations-children-with-infantile-hemangiomas-ihs-interventions-early-referral-comparators-delayed-referral-outcomess-minimization-of-functional-impairment-andor-cosmetic-deformity-pico-2-populations-children-with
    November 14, 2013 - long-term cosmetic deformity Pain and/or bleeding associated with ulceration Avoidance of unnecessary sedation … corticosteroids Risks of laser treatment (changes in skin pigmentation, ulceration) Risks associated with sedation

19. Executive Summary - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
    January 01, 2023 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … high-THC to CBD) may be associated with small improvement in pain severity, but with increased risk of sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … placebo, these interventions resulted in greater risk of common adverse events (dizziness, nausea, sedation

20. Pbt-Lsr-Draft-Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbt-lsr-draft-report.pdf
    February 04, 2022 - There was a large increased risk of dizziness and sedation and a moderate increased risk of nausea ( … dizziness: 6 RCTs, N=866, 30% vs. 8%, relative risk [RR] 3.57, 95% CI 2.42 to 5.60, I2=0%; sedation: … There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … More patients in the gabapentin group reported sedation (60%) than in the nabilone 20 group … Important harms include typical adverse effects such as dizziness, sedation and nausea, but may also